Target(s)
- Juno PC Holdings Pty Ltd
Summary
iNova Pharmaceuticals (Australia) Pty Ltd is proposing to acquire Juno PC Holdings Pty Ltd.
iNova supplies, amongst other products, prescription weight loss medication containing phentermine as an active ingredient. Juno PC is currently developing prescription weight loss medication with the same active ingredient.
Market inquiries
Submissions are invited from interested parties regarding the proposed acquisition by 13 September 2019.
Submissions should be forwarded electronically (preferably in PDF format) to mergers@accc.gov.au with the title: “Submission re: iNova/Juno PC - attention Adrian Hughes/Andy Gallagher." Alternatively submissions may be mailed to the Merger Investigations Branch, ACCC, GPO Box 3131 Canberra ACT 2601.
Following 13 September 2019, queries regarding the ACCC's review may be addressed to Adrian Hughes or Andy Gallagher at mergers@accc.gov.au.
For more details please refer to the Market Inquiries letter below.
ACCC correspondence
Timeline
| Date | Event |
|---|---|
| 30/08/2019 | ACCC commenced informal review under the Informal Merger Review Process Guidelines. |
| 13/09/2019 | Closing date for submissions. |
| 10/10/2019 | ACCC is awaiting information from the merger parties. Former provisional date for announcement of findings 31 October is delayed. ACCC will announce a proposed decision date in due course. |
Project staff
- Adrian Hughes
- Andrew Gallagher